Sime Diagnostics Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 33

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $4.36M

  • Investors
  • 7

Sime Diagnostics General Information

Description

Provider of an artificial intelligence-based healthcare platform intended to deliver decisive data-driven results in minutes. The company's platform offers accuracy as a neonatal clinical tool and its effectiveness as a biomarker discovery platform, enabling doctors to discover new disease biomarkers and curate unique datasets.

Contact Information

Website
www.simedx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 43 Manchester Street
  • London W1U 7LP
  • England, United Kingdom

Sime Diagnostics Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sime Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC 15-Mar-2022 $4.36M 00.000 000.00 Completed Generating Revenue
10. Later Stage VC 01-Apr-2021 00000 00.000 000.00 Completed Generating Revenue
9. Later Stage VC 12-May-2020 00.000 00.000 000.00 Completed Generating Revenue
8. Later Stage VC 26-Feb-2019 00.000 00.000 00.000 Completed Generating Revenue
7. Grant 11-Jan-2018 00.000 00000 Completed Generating Revenue
6. Accelerator/Incubator 00000 Completed Generating Revenue
5. Accelerator/Incubator 01-Jan-2017 00000 Completed Generating Revenue
4. Early Stage VC 31-Dec-2016 00000 00000 00.000 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2016 $125K Completed Generating Revenue
2. Accelerator/Incubator $125K Completed Startup
To view Sime Diagnostics’s complete valuation and funding history, request access »

Sime Diagnostics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preferred Ordinary 000,000 00.000000 000.00 000.00 00 000.00 00.000
Ordinary 000,000 00.000000 000.00 000.00 00 000.00 00.000
Ordinary 00,000 00.000000 00.00 00.00 00 00.00 0.000
Ordinary 000,000 00.000000 00.00 00.00 00 00.00 0.000
Ordinary 000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary 00,000 00.000000 00.00 00.00 00 00.00 0.000
Ordinary 35,545 $0.000134 $2.82 $2.82 1x $2.82 1.95%
Ordinary 61,217 $0.000134 $2.3 $2.3 1x $2.3 3.36%
To view Sime Diagnostics’s complete cap table history, request access »

Sime Diagnostics Patents

Sime Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4162279-A1 Methods and systems for predicting ards Pending 04-Jun-2020 000000000
US-20230223150-A1 Methods and systems for predicting ards Pending 04-Jun-2020 000000000
EP-4127712-A1 Systems and methods for predicting a risk of development of bronchopulmonary dysplasia Pending 26-Mar-2020 00000000000
US-20230160818-A1 Systems and methods for predicting a risk of development of bronchopulmonary dysplasia Pending 26-Mar-2020 000000000
EP-3692376-A1 Lamellar body purification for diagnosis and treatment of a disease or disorder Inactive 06-Oct-2017 G01N33/92
To view Sime Diagnostics’s complete patent history, request access »

Sime Diagnostics Executive Team (10)

Name Title Board Seat Contact Info
Povl Verder Co-Founder, Chief Executive Officer & Board Member
Hugh Reid Chief Technology Officer
Henrik Verder Co-Founder & Clinician
Agnar Höskuldsson Co-Founder & Mathematician
Morgaine Matthews Head, Product
You’re viewing 5 of 10 executive team members. Get the full list »

Sime Diagnostics Board Members (8)

Name Representing Role Since
Manuel Pinuela Ph.D Self Board Member 000 0000
Michael Trevino Self Chairman 000 0000
Morten Henneveld Self Board Member 000 0000
Palle Andersen Self Non Executive Chairman 000 0000
Povl Verder Sime Diagnostics Co-Founder, Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Sime Diagnostics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sime Diagnostics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Consilience Ventures Venture Capital Minority 000 0000 000000 0
Oxford Technology Management Venture Capital Minority 000 0000 000000 0
Horizon 2020 SME Instrument Government 000 0000 000000 0
Grow London Accelerator/Incubator Minority 000 0000 000000 0
DigitalHealth.London Accelerator Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »